• Skip to Content

.

 Indiana University Indiana University IU

Search

IU Simon Comprehensive Cancer Center Indiana University Melvin and Bren Simon Comprehensive Cancer CenterA National Cancer Institute Comprehensive Cancer Center

  • About Us
    • Our Mission & Goals
    • Our Leadership
    • Our Members (Scientists, Physician-scientists)
    • Our Partners
    • Travel
  • Research & Clinical Trials
    • Clinical Trials
    • Research Programs
    • DHART SPORE
    • Member Directory
    • Become a Member
    • Shared Facilities
    • Research Resources
    • Funding Opportunities
    • Refer a Patient
  • Career Enhancement & Related Activities
    • Aims
    • Training Programs
    • Trainee Membership
    • Fellowships
    • Presentations
    • Cancer Research Day
    • Amelia Project
    • Andrea Gianaris Pancreatic Cancer Symposium
    • William J. Wright Scholarship Fund
  • News & Publications
    • News
    • News Archives
    • Publications
  • Office of Community Outreach & Engagement
  • Giving
Staff Login
  • Patient Care at IU Health
  • IU School of Medicine
  • Research & Clinical Trials
  • Clinical Trials
  • Find a Trial
  • Trial Results

Research & Clinical Trials

Find a Trial

Trial Results


4 protocol(s) meet the specified criteria
20170543OPEN TO ACCRUAL
A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100).
CTO-20180144OPEN TO ACCRUAL
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 256 in Patients With Advanced Solid Tumors
CTO-20190135OPEN TO ACCRUAL
A Phase 1b/2, Master Protocol Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 510 (pINN Sotorasib) in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation
CTO-LOXO-RAS-20001OPEN TO ACCRUAL
A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors
  • Clinical Trials
    • About Clinical Trials
    • Should I Participate?
    • Find a Trial
      • by Cancer Type
      • by Doctor
      • by Institution
    • Biobanking: Donating a Part of You to Help Find a Cure.
    • Scientific Review Committee Resources
  • Research Programs
  • DHART SPORE
  • Member Directory
  • Become a Member
  • Shared Facilities
  • Research Resources
  • Funding Opportunities
  • Refer a Patient
NCI-CC A Cancer Center Designated by the National Cancer Institute Big 10 Cancer Research Consortium
Give Now
Fundraising Disclosures: http://go.iu.edu/89n

Block IU Copyright ©  The Trustees of Indiana University, Copyright Complaints, Privacy Notice

Indiana University Melvin and Bren Simon Comprehensive Cancer Center | 535 Barnhill Drive | Indianapolis, IN 46202
Patient Care: (888) 600-4822 | Administrative Office: (317) 278-0070

For accessibility or website issues, contact the webmaster.